Strengthen Credibility, Trust & Impact & Deliver Sustainable Reputation Communications Excellence For Pharma & Healthcare
08.30 Registration & Informal Networking
OPENING REMARKS
09.00 GIC Welcome & Morning Chair’s Opening Remarks
Rachel James-Owens , Vice President Corporate Communications and Media Relations, Zealand Pharma
Strategic Leveraging Of AI In Communications
OPENING KEYNOTE
09.10 Harness AI Make Communication Functions More Operable, Provide Insights and Boost Cross-Functional Collaboration
- Go beyond the use of AI as just a time saving application and harness the strategic implementation of AI for communicators and its demonstrable business impact
- How is AI influencing the information landscape and what impact is that having on trust, credibility and perception in the pharma industry?
- Evolve or perish! Adapt to constantly changing AI developments and evolve alongside AI to keep pace with tech changes
Krysia Sommers, Head of Strategic and Executive Communications, Bayer
Effective Patient Partnerships
PANEL Q&A
09.30 Harness Patient Influence, New Channels & Shared Expertise to Shape Meaningful Partnerships & Deliver Demonstrable Impact
- Amplify patient voices and going beyond storytelling to build long-term relationships and trust between patients, patient groups and pharma companies
- Harness the rise of the patient as an influencer and maximise the value of collaborative relationships for greater reach through trusted voices
- Find the balance between the clinical expertise of pharma and the patients’ lived experience to promote co-creation and shared decision making
- How can Pharma and patients collaborate on campaign-led patient advocacy and deliver tangible examples of impactful patient partnerships?
Gabor Purman, Patient Advocacy Director, Kyowa Kirin
Lisa Timothy, Head of Public Affairs & Patient Advocacy, Takeda
Pia Beltrao Hansen, Senior Director, Head of Commercial Communications, Ascendis Pharma
Claire Murray, Executive Director, Client Services, Spectrum Science
Disease Awareness
KEYNOTE
10.00 Adapt Disease Awareness to Changing Patient Behaviours Through Trusted & Inclusive Communications That Inform and Build Connections
- Make use of practical approaches to disease awareness with contents that that bring accurate information and real patient experiences together to amplify impact
- Identify the changes in the way patients interact with healthcare and adapt approaches to disease awareness to reflect both their information needs and lived experiences
- How can organisations tackle the rise of misinformation with meaningful contributions to patient education and awareness?
- Enforce allyship across disease areas that recognises the diversity of patient voice and go beyond box-ticking, creating space for sharing experiences that reflect the realities behind each condition
Alessandra Fonseca, Global External Communication Director, Kedrion Biopharma
10.20 Bonus Session Reserved for Conference Partner – Resolver
10.35 Morning Refreshment Break with Informal Networking
If Misinformation Can Scale on Social, Why Can't Science?
11.05 Rethinking pharma’s influence in the creator era
- Why the rules of influence in healthcare have changed and expertise alone is no longer enough to drive attention or trust
- How the way people discover and consume information is creating a growing influence gap for pharma
- What organisations need to do now to build creator ecosystems that make credible science more discoverable, influential and culturally relevant
Emma Robertson, Associate Director, Social Media, Langland
Geopolitics: Agility in Uncertainty
PANEL Q&A
11.20 Balance Agility & Messaging Consistency As Geopolitical Forces Reshape Reputation & Drive Durable Organisational Reputation
- How can pharma companies preserve identity under the pressure of political polarisation and remain a trusted voice amongst patients?
- How can organisations develop comms strategies that are agile, flexible and durable enough to withstand volatile external conditions?
- How can teams communicate strategically during times of tension, balancing values, business interested and external stakeholders into a consistent narrative?
Rene Rust, Head of Corporate Communications and Government Affairs, Almirall
Diana Trojanus, Communications Director, EMEA Region, Merz Aesthetics
Lucie Sabikova, Head of Communications MCO Eastern Europe, Takeda
11.20 Bonus Session; Reserved For Exclusive Conference Partner
Why Pharma Needs To Start Treating Social Media As Social Media
KEYNOTE SESSION
11.50
- Why Pharma Still Struggles on Social Media – The impact of risk aversion and reputation concerns, how compliance is often blamed when mindset is the real barrier
- Social Media Isn’t a Digital Noticeboard – The difference between publishing and participating, and why audiences engage with people and stories, not only corporate messaging
- Challenging Assumptions About Audiences – Case study of TikTok in the care sector and what happened when audience behavior was prioritised
- The Opportunity for Pharma and Practical Actions for Teams to take away with them
Katie Vickers, Social Media & Digital Communications Manager, AbbVie
12.10 Bonus Session Reserved for Conference Partner – Waggener Edstrom Worldwide Ltd.
12.30 Lunch Break & Informal Networking
13.00 Peer To Peer Discussion Zones
A) AI as a Tool in Comms
Laura Chamley, Senior Director Public Affairs, Gilead Sciences
B) Strategic Role of Comms
Mark Grossien, Head of Strategic Communications, Sandoz
13.30 Afternoon Co-Chairs’ Opening Remarks
Marina Moustaka, Director, International Medical Communications, Abbvie
Karen Borrer, Head of Communications, UCB
13.40 The Trust Gap: Why Expertise Isn’t Enough
Session overview
In pharma and healthcare, credibility is built on expertise, evidence and trusted relationships. But when it comes to communicating, expertise alone isn’t always enough.
Every interaction sends signals that either reinforce or weaken trust before your audience has fully considered your message. Whether you’re speaking to HCP’s, patients, colleagues or the media, the way your expertise comes across can have just as much impact as the expertise itself.
In this interactive session with Alina Jenkins from Body Talk, we’ll explore one often overlooked element of credibility: presence. You’ll discover how subtle behavioural cues influence trust and leave with one simple technique you can apply immediately to communicate with greater impact.
Key takeaways
- Why expertise is only one part of credibility.
- How audiences form impressions that influence trust from the moment you begin communicating.
- The subtle behaviours that can either strengthen or undermine your presence.
- One practical technique to help you communicate with greater confidence and credibility
Alina Jenkins, Head of Communications & Training, Body Talk
Evolving Stakeholder Ecosystems
PANEL Q&A
14.00 Navigate Complex Stakeholder Landscapes with Cohesive Strategies that Drive Collaboration & Trust
- How can teams leverage integrated communication plans to promote collaboration with different stakeholder groups?
- Streamline communications through multiple channels to meet the needs of complex stakeholder audiences
- Maximise the impact of comms strategies across key audiences and build trust in a changing environment
Chiara Antoniucci, Global External & Internal Communication Director, Angelini Pharma
Eoin Weldon, Head of EMEA Communications, Merck Life Sciences
Katherine Jordan, Senior Director for Corporate Affairs, Novo Nordisk
Jérôme Dévé, Director of External Communications, Pfizer
Luke Willats, Head of Global Communications & Strategic Affairs, Merz Therapeutics
Marie-Louise Møller Lange, Head of IO RA Policy & Advocacy, Novo Nordisk
Misinformation, Trust & Credibility
KEYNOTE
14.40 Turn Insights into Action: Measurable Strategies To Combat Misinformation & Build Lasting Trust Across Stakeholder Audiences
- How can organisations become a trusted tone of voice in the age of misinformation and scepticism around healthcare products and services?
- How can the healthcare system shape perception and build brand credibility in an era where reactionary or misinformed information travels at lightening speed?
- How can industry contribute to the prevention of misinformation, and not just intervention when it emerges?
Robert Ede, Senior Director and Head of Corporate Affairs, Lilly
Building Reputation – ABPI’s Value of Industry Campaign
KEYNOTE
15.00
Andy Collier, Senior Policy Manager – Reputation, ABPI
Measuring Impact in Pharma Comms
DELEGATE DISCUSSION
15.20 Turn Insights into Action: Measurable Strategies To Combat Misinformation & Build Lasting Trust Across Stakeholder Audiences
- How can organisations become a trusted tone of voice in the age of misinformation and scepticism around healthcare products and services?
- How can the healthcare system shape perception and build brand credibility in an era where reactionary or misinformed information travels at lightening speed?
- How can industry contribute to the prevention of misinformation, and not just intervention when it emerges?
15.40 Afternoon Refreshment Break with Informal Networking
Reputation Management
KEYNOTE
16.10 Safeguard Trust Through Proactive, Coordinated & Data Informed Reputation Management
- How can organisations identify early signals of reputational risk and develop proactive strategies to mitigate issues?
- Leverage data and stakeholder intelligence to inform reputation strategy and guide decision making
- How can professionals proactively protect organisational reputation in such a fast-paced and heavily scrutinised healthcare environment?
Marco Gerometta, Communications Director – Global Clinical Operations, R&D, GSK
Health Equity
FIRESIDE CHAT
Alvaro Ingles Prieto, Senior Manager Innovation Unit Communications, Corporate Affairs, Boehringer Ingleheim
Compliance without Constraint
KEYNOTE
16.50 Create Flexible, Compliant Communication Strategies That Can Adapt To Evolving Policy Demands
- How can teams ensure alignment and compliance across cross-market communications?
- Dive into the role of communications in shaping and responding to policy developments across healthcare systems
- Stay ahead of shifting regulations by building agile processes that can respond to change without compromising quality or integrity
17.10 Afternoon Co-Chairs’ Closing Remarks & End of Conference
